Document is current
Any future updates will be listed below
-
Authors
Park, Hyun Jin
Shin, Chang Ho
Yoo, Won Joon
Cho, Tae-Joon
Kim, Man Jin
Seong, Moon-Woo
Park, Sung Sup
Lee, Jeong Ho
Sim, Nam Suk
Ko, Jung Min https://orcid.org/0000-0002-0407-7828
-
Funding
Funding for this research was provided by:
Ministry of Education (800-20190543)
- License Information
-
More Information
Article History
Received: 18 May 2020
Accepted: 26 July 2020
First Online: 10 August 2020
Ethics approval and consent to participate
: The study was approved by the institutional review board of Seoul National University Hospital (H-1908-092-1055).
: Not applicable.
: J.H.L. is a co-founder and Chief Technology Officer of SoVarGen, Inc., a Korean company that develops new diagnostics and therapeutics for brain disorders.
